New research conducted by the National Institutes of Health is shedding light on how COVID-19 affects patients’ brains.

Researchers reported evidence of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting COVID-19. However, there were no signs of SARS-CoV-2 in tissue samples, suggesting the damage was not caused by a direct viral attack on the brain.

NIH Dec. 22 also announced it paused enrollment for one group of patients participating in three clinical trial platforms working in conjunction with one another to test the effects of full doses of anticoagulants in COVID-19 patients.

Researchers determined that among critically ill COVID-19 patients requiring intensive care unit support, therapeutic anticoagulation drugs did not reduce the need for organ support. The trials will continue enrollment of moderately ill hospitalized COVID-19 patients.

Several other NIH-led studies are also providing new insights in the following areas:

  • the likelihood of SARS-CoV-2 infection transmission between third-trimester pregnant women and newborns;
  • a series of investigations into risk factors for COVID-19-related inflammatory syndrome in children; and
  • support for new, non-traditional approaches and reimagined uses of existing tools to address gaps in COVID-19 testing and surveillance.

Related News Articles

The AHA yesterday joined the U.S. Chamber of Commerce and American Medical Association in urging the 11th Circuit Court of Appeals to void a district court…
All clinicians should get vaccinated against COVID-19, encourage their staff and patients to get vaccinated, and recommend immunocompromised patients continue…
The AHA, America’s Essential Hospitals, Association of American Medical Colleges, Catholic Health Association of the United States, and Children’s Hospital…
The Centers for Disease Control and Prevention today adjusted its guidance for fully vaccinated individuals, urging indoor masking in states that are labeled…
The Health Resources and Services Administration today awarded 127 organizations a total of $121 million in American Rescue Plan Act funds to work with…
The Food and Drug Administration last week issued an emergency use authorization to Becton, Dickinson and Company for its sodium citrate blood specimen…